Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Understanding Your LabsUnderstanding Your Labs
          
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Viral load detectable for the first time
Dec 29, 2000

Please advise what you would do if, for the first time since beginning treatment (Abacavir, Neverapine, 3TC) 2-1/2 years ago, your VL became detectable by ultrasensitive assay (105). How soon should I retest? After how many detectable results should I consider changing meds? Should I do resistance testing before making another medication choice? (47-yr.-old woman, nine years positive, average 300-400 CD4 cells). Many thanks!

Response from Dr. Holodniy

I would test again in a month or so, and see if this was just a "blip", in which case it will be back below 50, or a significant trend, in which case it will probably be higher. A resistance will not be possible if the viral load is still 100. Most reference labs require a viral load of > 1,000 in order to have enough HIV copies to do the test.

MH



Previous
Age and CD4 Counts
Next
VL for HIV 2 and

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement